Multiclonal dissemination of ptxP3 allele macrolide-resistant Bordetella pertussis in Okinawa, Japan.

An ongoing pertussis epidemic in Okinawa has resulted in 227 reported cases since November 2024. Between December 2024 and February 2025, clinical specimens were collected from 31 cases. We isolated 18 macrolide-resistant Bordetella pertussis (MRBP) strains, all harboring the A2047G mutation in the 23S rRNA gene, confirmed by real-time PCR.

Severe macrolide-resistant Bordetella pertussis (ptxP3) infection in Japanese infants: First report of cases requiring intensive care.

In November 2024, two unvaccinated infants with ptxP3 allele-carrying macrolide-resistant Bordetella pertussis (MRBP) infection were admitted to a hospital in Okinawa, Japan, and required intensive care. These represent the first reported severe MRBP cases in Japan. Both tested positive via LAMP and failed initial macrolide therapy, requiring mechanical ventilation and a switch to trimethoprim-sulfamethoxazole.

Genomic and pathogenicity analyses to identify the causative agent from multiple serogroups of non-O1, non-O139 in foodborne outbreaks.

In 2013, foodborne outbreaks in Japan were linked to non-O1, non-O139 . However, laboratory tests have detected several serogroups, making it difficult to determine the causative agent. Therefore, whole-genome analyses revealed that only serogroup O144 possesses a genomic island with a type III secretion system (T3SS).

Emergence of Ceftriaxone-Resistant Neisseria gonorrhoeae Through Horizontal Gene Transfer Among Neisseria Species.

Background: It has been suggested that the emergence of ceftriaxone-resistant strains of Neisseria gonorrhoeae involves the incorporation of the penA gene from commensal Neisseria spp that are resistant to ceftriaxone. However, the mechanism of this mosaic penA generation is unknown.

Methods: We obtained 10 strains of commensal Neisseria spp showing ceftriaxone minimum inhibitory concentration ≥0.

Individual Atg8 paralogs and a bacterial metabolite sequentially promote hierarchical CASM-xenophagy induction and transition.

Atg8 paralogs, consisting of LC3A/B/C and GBRP/GBRPL1/GATE16, function in canonical autophagy; however, their function is controversial because of functional redundancy. In innate immunity, xenophagy and non-canonical single membranous autophagy called "conjugation of Atg8s to single membranes" (CASM) eliminate bacteria in various cells. Previously, we reported that intracellular Streptococcus pneumoniae can induce unique hierarchical autophagy comprised of CASM induction, shedding, and subsequent xenophagy.

Combined usage of serodiagnosis and O antigen typing to isolate Shiga toxin-producing O76:H7 from a hemolytic uremic syndrome case and genomic insights from the isolate.

Hemolytic uremic syndrome (HUS) is a life-threatening disease caused by Shiga toxin-producing (STEC) infection. The treatment approaches for STEC-mediated typical HUS and atypical HUS differ, underscoring the importance of rapid and accurate diagnosis. However, specific detection methods for STECs other than major serogroups, such as O157, O26, and O111, are limited.

Characterization of in northern Vietnam in 2012-2016.

Introduction: Shigellosis remains a considerable public health concern in developing countries. and are prevalent worldwide and has been replacing .

Gap Statement: still causes outbreaks of shigellosis in northern Vietnam but limited information is available on its genetic characteristics.

A bivalent outer membrane vesicle-based intranasal vaccine to prevent infection of periodontopathic bacteria.

Periodontal disease has become a serious public health problem, not only causing tooth loss, but also inducing chronic disorders of extra-oral organs. The present study assessed an intranasal vaccine strategy to prevent periodontal disease using outer membrane vesicles (OMVs) of two major periodontopathic bacteria, Porphyromonas gingivalis (Pg) and Aggregatibacter actinomycetemcomitans (Aa). We compared the morphology, composition, and immune activity between OMVs of Pg strain ATCC 33277 and Aa strain Y4.

Multidrug-resistant isolate SE690: mosaic gene causing ceftriaxone resistance internationally has spread to the more antimicrobial-susceptible genomic lineage, Sweden, September 2022.

We report a ceftriaxone-resistant, multidrug-resistant urogenital in a female sex worker in Sweden, September 2022, who was treated with ceftriaxone 1 g, but did not return for test-of-cure. Whole genome sequencing of isolate SE690 identified MLST ST8130, NG-STAR CC1885 (new NG-STAR ST4859) and mosaic . The latter, causing ceftriaxone resistance in the internationally spreading FC428 clone, has now also spread to the more antimicrobial-susceptible genomic lineage B, showing that strains across the gonococcal phylogeny can develop ceftriaxone resistance.

Molecular mechanism of Streptococcus pneumoniae-targeting xenophagy recognition and evasion: Reinterpretation of pneumococci as intracellular bacteria.

Streptococcus pneumoniae is a major, encapsulated Gram-positive pathogen that causes diseases including community-acquired pneumonia, meningitis, and sepsis. This pathogen colonizes the nasopharyngeal epithelia asymptomatically but can often migrate to sterile tissues and cause life-threatening invasive infections (invasive pneumococcal disease). Although multivalent pneumococcal polysaccharides and conjugate vaccines are available and effective, they also have major shortcomings with respect to the emergence of vaccine-resistant serotypes.

Genomic attributes of Vibrio cholerae O1 responsible for 2022 massive cholera outbreak in Bangladesh.

In 2022, one of its worst cholera outbreaks began in Bangladesh and the icddr,b Dhaka hospital treated more than 1300 patients and ca. 42,000 diarrheal cases from March-1 to April-10, 2022. Here, we present genomic attributes of V.

Complete Reference Genome Sequence of the Clinical Neisseria gonorrhoeae Strain H035, with Resistance to the Novel Antimicrobial Zoliflodacin, Identified in Japan in 2000.

Zoliflodacin is a promising novel antimicrobial in clinical development for treatment of gonorrhea; currently, it is in a global phase 3 randomized controlled clinical trial. High activity against global Neisseria gonorrhoeae strains has been shown. We present the complete reference genome of the zoliflodacin-resistant strain H035, which was identified in Japan in 2000.